📊 Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
62
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
45%
💰 Capital Raise
55%
• Critical: only 2.8 months cash remaining
📉 Score Deterioration
50%
• Score rose 45 points recently (worsening)
• Score in HIGH risk zone (72/100)
🔄 Reverse Split
15%
• Only 3 months cash — financial pressure
💹 Market Data
Market Cap$145.09M
Shares Outstanding40.99M
Float8.73M
Cash$14.96M
Debt$86.17M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 47.7% shares (2025Q4 vs prior)
16 institutional holders · 927.9K shares
#1
Pacific Ridge Capital Partners, LLC
430.0K shares
#2
THOMPSON DAVIS & CO., INC.
124.7K shares
#3
1492 Capital Management LLC
102.6K shares
+ 13 more holders Sign up free to view →
📉 Short Interest
Short Interest16.1K
Days to Cover1.0
% of Float0.2%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 16, 2026
4
INSIDER TRANSACTION
Mar 20, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SHIM
📊 SHIM FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SHIM Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.